BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24567186)

  • 1. Functional analysis of three novel cell lines derived from human papillary thyroid carcinomas with three different clinical courses.
    Ishikawa M; Tachibana T; Hashimoto H; Toyomura J; Ito T; Tsuboi K; Shibuya K; Hirose T; Minami S; Yoshino G
    Hum Cell; 2014 Jul; 27(3):111-20. PubMed ID: 24567186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a neck lump as a lymph node metastasis from an occult contralateral papillary microcarcinoma of the thyroid: key role of thyroglobulin assay in the fine-needle aspirate.
    Bruno R; Giannasio P; Chiarella R; Capula C; Russo D; Filetti S; Costante G
    Thyroid; 2009 May; 19(5):531-3. PubMed ID: 19416000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of thyroglobulin measurement in needle washouts of fine-needle aspiration biopsy for the diagnosis of cervical lymph node metastases from papillary thyroid cancer before thyroidectomy.
    Kim DW; Jeon SJ; Kim CG
    Endocrine; 2012 Oct; 42(2):399-403. PubMed ID: 22350587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived growth factor receptor-α promotes lymphatic metastases in papillary thyroid cancer.
    Zhang J; Wang P; Dykstra M; Gelebart P; Williams D; Ingham R; Adewuyi EE; Lai R; McMullen T
    J Pathol; 2012 Oct; 228(2):241-50. PubMed ID: 22744707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroglobulin in washout fluid from lymph node fine-needle aspiration biopsy in papillary thyroid cancer: large-scale validation of the cutoff value to determine malignancy and evaluation of discrepant results.
    Moon JH; Kim YI; Lim JA; Choi HS; Cho SW; Kim KW; Park HJ; Paeng JC; Park YJ; Yi KH; Park DJ; Kim SE; Chung JK
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1061-8. PubMed ID: 23393171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDGFRα Regulates Follicular Cell Differentiation Driving Treatment Resistance and Disease Recurrence in Papillary Thyroid Cancer.
    Lopez-Campistrous A; Adewuyi EE; Benesch MGK; Ko YM; Lai R; Thiesen A; Dewald J; Wang P; Chu K; Ghosh S; Williams DC; Vos LJ; Brindley DN; McMullen TPW
    EBioMedicine; 2016 Oct; 12():86-97. PubMed ID: 27682510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
    Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
    J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
    Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
    Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
    Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
    Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathologic and molecular features of cribriform morular variant of papillary thyroid carcinoma].
    Cui XJ; Zhao HO; Su P; Chen J; Zhang RY; Pan Y; Ouyang XM; Liu J; Zhang JQ; Yang Y; Yang R; Ding L; Liu ZY
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):354-359. PubMed ID: 29783802
    [No Abstract]   [Full Text] [Related]  

  • 12. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
    Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
    J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
    Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H
    Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of TLR4 by LMW-HA induces metastasis in human papillary thyroid carcinoma through CXCR7.
    Dang S; Peng Y; Ye L; Wang Y; Qian Z; Chen Y; Wang X; Lin Y; Zhang X; Sun X; Wu Q; Cheng Y; Nie H; Jin M; Xu H
    Clin Dev Immunol; 2013; 2013():712561. PubMed ID: 24363762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distant, solitary skeletal muscle metastasis in recurrent papillary thyroid carcinoma.
    Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Choe JH; Kim JH; Kim JS
    Thyroid; 2011 Sep; 21(9):1027-31. PubMed ID: 21834676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroglobulin measurements in fine-needle aspiration cytology of lymph nodes for the detection of metastatic papillary thyroid carcinoma.
    Li QK; Nugent SL; Straseski J; Cooper D; Riedel S; Askin FB; Sokoll LJ
    Cancer Cytopathol; 2013 Aug; 121(8):440-8. PubMed ID: 23495036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of Papillary Thyroid Carcinoma into Tall Cell Variant and TENIS Syndrome.
    Chakraborty A; Kane SV; Pawer Y; Basu S
    J Nucl Med Technol; 2016 Dec; 44(4):255-258. PubMed ID: 27834723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
    Michelotti G; Jiang X; Sosa JA; Diehl AM; Henderson BB
    Oncotarget; 2015 Oct; 6(33):34549-60. PubMed ID: 26416247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness.
    Kurtulmus N; Duren M; Ince U; Cengiz Yakicier M; Peker O; Aydın O; Altiok E; Giray S; Azizlerli H
    Endocrine; 2012 Oct; 42(2):404-10. PubMed ID: 22426956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Pleiotrophin Concentrations in Papillary Thyroid Cancer.
    Jee YH; Sadowski SM; Celi FS; Xi L; Raffeld M; Sacks DB; Remaley AT; Wellstein A; Kebebew E; Baron J
    PLoS One; 2016; 11(2):e0149383. PubMed ID: 26914549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.